<DOC>
	<DOCNO>NCT00712725</DOCNO>
	<brief_summary>The purpose study demonstrate effectiveness appropriate dosage level MK3207 treatment acute migraine .</brief_summary>
	<brief_title>MK3207 Treatment Acute Migraines ( 3207-005 )</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Men Women 18 65 year age 1+ year history migraine typically last 4 72 hour untreated Had 2 8 moderate severe migraine attack per month last 2 month Not pregnant plan become pregnant next 6 month Pregnant breastfeeding , plan become pregnant next 6 month Can distinguish migraine attack tension type headache Migraines mild resolve without medication le 2 hour More 15 headachedays per month take medication 10 day per month last 3 month Basilar type hemiplegic migraine headaches More 50 year old migraine begin History cardiovascular disorder within last 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>